Thomas A. MCCOURT - 08 Mar 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Tessler, Attorney-in-Fact
Issuer symbol: IRWD
Transactions as of: 08 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 10 Mar 2023, 16:09:42 UTC
Previous filing: 08 Mar 2023
Next filing: 29 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Award	$0	+240,595	+37%	$0.000000	888,193	08 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRWD	Performance-based Restricted Stock Units	Award	$0	+120,297		$0.000000	120,297	08 Mar 2023	Class A Common Stock	120,297		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
F2	Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.